This one-day conference will provide participants with the most up-to-date and clinically relevant information presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, the 2026 ESMO Congress, and other key oncology conferences held throughout the year. Through didactic lectures, case studies, and interactive sessions, subject matter experts will present analyses highlighting practice-changing data and discussing how these advances should influence clinical decision-making and patient care in oncology. 

Target Audience

• Physicians
• Advanced Practice Providers
• Nurses
• Residents
• Students

Learning Objectives

• Describe recent advances in the treatment of breast, lung, gastrointestinal, genitourinary, head and neck cancers, melanoma, and hematologic malignancies.
• Interpret key clinical trial results presented at major oncology meetings and discuss their relevance to clinical practice today.
• Integrate multimodality treatment strategies including systemic therapy, immunotherapy, targeted therapy, and radiation therapy into patient management.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.